Literature DB >> 10898759

Hepatic preconditioning preserves energy metabolism during sustained ischemia.

C Peralta1, R Bartrons, L Riera, A Manzano, C Xaus, E Gelpí, J Roselló-Catafau.   

Abstract

We evaluated the possibility that ischemic preconditioning could modify hepatic energy metabolism during ischemia. Accordingly, high-energy nucleotides and their degradation products, glycogen and glycolytic intermediates and regulatory metabolites, were compared between preconditioned and nonpreconditioned livers. Preconditioning preserved to a greater extent ATP, adenine nucleotide pool, and adenylate energy charge; the accumulation of adenine nucleosides and bases was much lower in preconditioned livers, thus reflecting slower adenine nucleotide degradation. These effects were associated with a decrease in glycogen depletion and reduced accumulation of hexose 6-phosphates and lactate. 6-Phosphofructo-2-kinase decreased in both groups, reducing the availability of fructose-2, 6-bisphosphate. Preconditioning sustained metabolite concentration at higher levels although this was not correlated with an increased glycolytic rate, suggesting that adenine nucleotides and cAMP may play the main role in the modulation of glycolytic pathway. Preconditioning attenuated the rise in cAMP and limited the accumulation of hexose 6-phosphates and lactate, probably by reducing glycogen depletion. Our results suggest the induction of metabolic arrest and/or associated metabolic downregulation as energetic cost-saving mechanisms that could be induced by preconditioning.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10898759     DOI: 10.1152/ajpgi.2000.279.1.G163

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  31 in total

Review 1.  Molecular mechanisms of liver preconditioning.

Authors:  Elisa Alchera; Caterina Dal Ponte; Chiara Imarisio; Emanuele Albano; Rita Carini
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  Role of ischaemic preconditioning in liver regeneration following major liver resection and transplantation.

Authors:  D Gomez; S Homer-Vanniasinkam; A M Graham; K R Prasad
Journal:  World J Gastroenterol       Date:  2007-02-07       Impact factor: 5.742

Review 3.  Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders.

Authors:  Benoit Viollet; Marc Foretz; Bruno Guigas; Sandrine Horman; Renaud Dentin; Luc Bertrand; Louis Hue; Fabrizio Andreelli
Journal:  J Physiol       Date:  2006-04-27       Impact factor: 5.182

4.  Ischemic preconditioning versus intermittent vascular inflow control during major liver resection in pigs.

Authors:  Vassilios Smyrniotis; Georgia Kostopanagiotou; Kassiani Theodoraki; Charalampos Farantos; Nikolaos Arkadopoulos; Evangelos Gamaletsos; Agathi Condi-Paphitis; Alexis Fotopoulos; Panagiotis Dimakakos
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

Review 5.  Cardioprotection by metabolic shut-down and gradual wake-up.

Authors:  Lindsay S Burwell; Sergiy M Nadtochiy; Paul S Brookes
Journal:  J Mol Cell Cardiol       Date:  2009-03-10       Impact factor: 5.000

6.  Histochemical approach of cryobiopsy for glycogen distribution in living mouse livers under fasting and local circulation loss conditions.

Authors:  Yurika Saitoh; Nobuo Terada; Sei Saitoh; Nobuhiko Ohno; Yasuhisa Fujii; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2009-12-01       Impact factor: 4.304

7.  Ischemic preconditioning confers antiapoptotic protection during major hepatectomies performed under combined inflow and outflow exclusion of the liver. A randomized clinical trial.

Authors:  Nikolaos Arkadopoulos; Georgia Kostopanagiotou; Kassiani Theodoraki; Charalambos Farantos; Theodosios Theodosopoulos; Vaia Stafyla; John Vassiliou; Dionyssios Voros; Agathi Pafiti; Vassilios Smyrniotis
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

Review 8.  Role of ischemic preconditioning in liver surgery and hepatic transplantation.

Authors:  Eduardo E Montalvo-Jave; Enrique Piña; Cesar Montalvo-Arenas; Raúl Urrutia; Luis Benavente-Chenhalls; Julieta Peña-Sanchez; David A Geller
Journal:  J Gastrointest Surg       Date:  2009-04-30       Impact factor: 3.452

9.  A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning.

Authors:  Pierre-Alain Clavien; Markus Selzner; Hannes A Rüdiger; Rolf Graf; Zakiyah Kadry; Valentin Rousson; Wolfram Jochum
Journal:  Ann Surg       Date:  2003-12       Impact factor: 12.969

10.  The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion.

Authors:  Carmen Peralta; José Carlos Perales; Ramón Bartrons; Claudia Mitchell; Hélène Gilgenkrantz; Carme Xaus; Neus Prats; Leticia Fernández; Emilio Gelpí; Julia Panés; Juan Roselló-Catafau
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.